Trials / Conditions / Refractory Head and Neck Squamous Cell Carcinoma
Refractory Head and Neck Squamous Cell Carcinoma
3 registered clinical trials studyying Refractory Head and Neck Squamous Cell Carcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returni NCT06589804 | National Cancer Institute (NCI) | Phase 3 |
| Recruiting | Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Rec NCT06211335 | University of California, Davis | Phase 1 |
| Recruiting | IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801 | M.D. Anderson Cancer Center | Phase 1 |